MyAverix Finance
HK · Healthcare
CF PharmTech Inc (2652)
Drug Manufacturers - Specialty & Generic
CF PharmTech Inc (2652) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-22, reported market cap is $7.21B, P/E ratio is 1,962.00, net margin is 0.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2652
CF PharmTech Inc (2652) — FAQ
What is CF PharmTech Inc's market cap?
CF PharmTech Inc (2652) has a reported market cap of $7.21B (data as of 2026-05-22).
What is 2652's P/E ratio?
The price-to-earnings (P/E) ratio for CF PharmTech Inc (2652) is 1,962.00 (data as of 2026-05-22).
Does CF PharmTech Inc pay a dividend?
Dividend yield is not available in the current snapshot for CF PharmTech Inc (2652). Check the MyAverix Finance app for the latest dividend data.
What sector is CF PharmTech Inc in?
CF PharmTech Inc (2652) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2652 listed on?
2652 is listed on HK.
What is CF PharmTech Inc's net margin?
CF PharmTech Inc (2652) reports a net margin of 0.6% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.